SHAH GAURAV (See Remarks) received a stock award from ROCKET PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/13/2026ACC: 0001140361-26-005412
DirectorOfficer· See Remarks
Since Jan 2019
+1.16M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.16M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+286.03K
Price / share
—
Trade value
—
% of position
36.8%
2/11/2026
778.30K→1.06M
Total
Net shares
+286.03K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/11/2026 | A · Award | +286.03K | — | — | 36.8% | 778.30K | 1.06M |
| Total | +286.03K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
870.65K shares
Shares
+870.65K
Strike price
3.24
Held after
870.65K
Exercisable
—
2/11/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock870.65K shares | 2/11/2026 | A · Award | +870.65K | 3.24 | — | 870.65K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned207.90K
Common Stock
IndirectShares owned198.34K
Total
406.24K indirect406.24K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 207.90K | Indirect |
| Common Stock | 198.34K | Indirect |
| Total | 406.24K | 406.24K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported